Coegin Pharma AB Earnings Call Transcripts

Fiscal Year 2024

Status Update

Follicopeptide, a novel hair growth peptide, is set for a Q4 2025 launch in Europe and the U.S., with production and regulatory processes on schedule. Clinical studies show over 70% efficacy, and commercialization will occur through established partners.

Read full transcript →